Back

Discrete genetic effects of VHL and PBRM1 inactivation co-operate to disrupt epithelial homeostasis and promote ccRCC

Kurlekar, S.; Lima, J. D. C. C.; Kupfer, N.; Pugh, C. W.; Mole, D. R.; Adam, J.; Ratcliffe, P. J.

2026-02-20 cancer biology
10.64898/2026.02.18.706657 bioRxiv
Show abstract

Inactivation of VHL is a truncal alteration in clear cell renal cell carcinoma, but additional events are required for oncogenesis, most commonly PBRM1 inactivation. To better understand this co-operation, we used an oncogenic cell-tagging strategy to analyze the earliest transcriptional and cellular consequences of Vhl and/or Pbrm1 inactivation in the renal tubular epithelium, in vivo, at single-cell resolution. Pbrm1 inactivation did not globally alter HIF-dependent transcription or increase early tubular proliferation induced by Vhl inactivation. Instead, it had independent effects on epithelial organization. Combined genetic and morphological analyses suggested that Pbrm1 inactivation allows cells to sustain Vhl/HIF-dependent proliferation by disrupting tubular architectures that ordinarily restrain this proliferation, resulting in extra-tubular cell accumulation, multilayered epithelia, and tumor formation. Our findings frame a new model for the VHL-PBRM1 interaction that explains loss of epithelial homeostasis through an interaction between discrete effects that drive proliferation and remove structural tissue restraints on that proliferation. Statement of SignificanceVHL and PBRM1 are frequently co-inactivated in ccRCC. Combining transcriptomic and histological analyses of Vhl and/or Pbrm1-inactivated renal cells in vivo, this study highlights independent effects on transcription and epithelial organization that converge to promote sustained proliferation and dysplasia. The work illuminates how tissue homeostasis is disrupted by oncogenic co-operation.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Developmental Cell
168 papers in training set
Top 0.9%
14.4%
2
Nature Communications
4913 papers in training set
Top 13%
12.6%
3
eLife
5422 papers in training set
Top 7%
9.2%
4
JCI Insight
241 papers in training set
Top 0.3%
7.2%
5
PLOS Genetics
756 papers in training set
Top 2%
7.2%
50% of probability mass above
6
Molecular Cancer Research
42 papers in training set
Top 0.1%
4.9%
7
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 20%
3.6%
8
Development
440 papers in training set
Top 1%
2.6%
9
Journal of Clinical Investigation
164 papers in training set
Top 2%
2.6%
10
Cell Reports
1338 papers in training set
Top 20%
2.4%
11
PLOS Biology
408 papers in training set
Top 9%
1.7%
12
Science Advances
1098 papers in training set
Top 18%
1.7%
13
The EMBO Journal
267 papers in training set
Top 2%
1.5%
14
Cancer Research
116 papers in training set
Top 2%
1.3%
15
Oncogene
76 papers in training set
Top 1%
1.3%
16
PLOS Pathogens
721 papers in training set
Top 8%
0.9%
17
Cell Reports Medicine
140 papers in training set
Top 6%
0.9%
18
The Journal of Physiology
134 papers in training set
Top 1%
0.9%
19
Genome Medicine
154 papers in training set
Top 7%
0.9%
20
PLOS Computational Biology
1633 papers in training set
Top 23%
0.8%
21
PLOS ONE
4510 papers in training set
Top 68%
0.7%
22
Scientific Reports
3102 papers in training set
Top 75%
0.7%
23
Cancers
200 papers in training set
Top 5%
0.7%
24
Molecular Biology of the Cell
272 papers in training set
Top 3%
0.7%
25
Genes & Development
90 papers in training set
Top 2%
0.6%
26
Nature Genetics
240 papers in training set
Top 8%
0.6%
27
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.6%
28
Life Science Alliance
263 papers in training set
Top 2%
0.6%
29
Cancer Discovery
61 papers in training set
Top 2%
0.5%
30
mBio
750 papers in training set
Top 13%
0.5%